A comparison of CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockages and the correspending FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention.
Feature | CT Angiography (CTA) | Dave Fornell, Editor

The use of non-invasive fractional flow reserve CT (FFR-CT) was the hottest topic discussed at the Society of ...

Home July 23, 2018
Home
Videos | Computed Tomography (CT)

Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of ...

Home July 23, 2018
Home
News | Embolic Protection Devices

July 20, 2018 — Boston Scientific Corp. today has signed an agreement to acquire Claret Medical Inc., which has ...

Home July 20, 2018
Home
Videos | CT Angiography (CTA)

Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine ...

Home July 19, 2018
Home
News

Here are the stories and other content in the July-August 2018 issue of Diagnostic and Interventional Cardiology (DAIC) ...

Home July 19, 2018
Home
News | Atherectomy Devices

Avinger Inc. announced in June that several physicians have successfully treated over 40 patients for peripheral artery disease (PAD) in the United States across 13 sites with the next-generation Pantheris image-guided atherectomy system. This positive initial case experience in the U.S. adds to the impressive clinical results achieved in the first 30 cases completed in Germany earlier this year and provides a strong foundation for expanded market launch into all U.S. accounts, according to the company.

Home July 18, 2018
Home
Technology | Heart Valve Technology

July 18, 2018 — Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next ...

Home July 18, 2018
Home
Videos

Suhny Abbara, M.D., FSCCT, chief of cardiothoracic imaging and chair of the CT operations committee, University of Texas ...

Home July 18, 2018
Home
Videos | CT Angiography (CTA)

A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino ...

Home July 18, 2018
Home
Videos | Heart Valve Technology

Jonathon Leipsic, M.D., FSCCT, professor of radiology and cardiology at the University of British Columbia, Vancouver ...

Home July 18, 2018
Home
Videos | Computed Tomography (CT)

An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Trial ...

Home July 17, 2018
Home
Videos | CT Angiography (CTA)

A discussion with Todd Villines, M.D., FACC, FAHA, FSCCT, director of cardiovascular research and cardiac CT programs at ...

Home July 17, 2018
Home
News | PET Imaging

A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.

Home July 17, 2018
Home
Technology | Ventricular Assist Devices (VAD)

Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device (LVAD) for patients with advanced heart failure. The HVAD System is the smallest commercially available LVAD according to Medtronic, and the only LVAD approved in the U.S. for implant via thoracotomy, a small lateral, surgical incision between the patient's ribs on the left side of the chest.

Home July 17, 2018
Home
News | Stent Grafts

Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair) registry at the 2018 Society for Vascular Surgery (SVS) Annual Meeting, June 21-23 in Boston. The LUCY study is the first to prospectively evaluate endovascular aneurysm repair (EVAR) outcomes in women who have more complex aortic anatomy and, subsequently, have worse reported outcomes than men undergoing EVAR. The results of the LUCY one-year data expand on the 30-day results presented last year, showing that at least 28 percent more women are eligible for minimally-invasive EVAR when using the Ovation Abdominal Stent Graft System than when using other EVAR systems.

Home July 16, 2018
Home
Subscribe Now